These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3906081)

  • 1. Aluminum metabolism and toxicity in renal failure: a review.
    Mayor GH; Lohr TO; Sanchez TV
    J Environ Pathol Toxicol Oncol; 1985; 6(1):43-50. PubMed ID: 3906081
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum and phosphate: the double bind.
    Kaye M; Gagnon R
    Am J Kidney Dis; 1985 Nov; 6(5):365-7. PubMed ID: 3904430
    [No Abstract]   [Full Text] [Related]  

  • 3. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
    Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Toxic effect of aluminum in chronic renal failure].
    Głuszek J
    Pol Tyg Lek; 1987 Nov; 42(48):1499-502. PubMed ID: 3451199
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ; Cowie JF; Robson JS
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract]   [Full Text] [Related]  

  • 6. Aluminum intoxication of bone in renal failure--fact or fiction?
    Malluche HH; Faugere MC; Smith AJ; Friedler RM
    Kidney Int Suppl; 1986 Feb; 18():S70-3. PubMed ID: 3458000
    [No Abstract]   [Full Text] [Related]  

  • 7. Aluminium ion: metabolism and toxicity.
    Berlyne GM; Rubin JE
    J Hum Nutr; 1977 Dec; 31(6):439-42. PubMed ID: 591720
    [No Abstract]   [Full Text] [Related]  

  • 8. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW
    Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
    [No Abstract]   [Full Text] [Related]  

  • 9. Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.
    Wills MR; Savory J
    Crit Rev Clin Lab Sci; 1989; 27(1):59-107. PubMed ID: 2647415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum and renal bone disease in Australia.
    Dunstan CR; Evans RA
    Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
    [No Abstract]   [Full Text] [Related]  

  • 11. Aluminum-induced dialysis osteodystrophy: the demise of "Newcastle bone disease"?
    Kerr DN; Ward MK; Arze RS; Ramos JM; Grekas D; Parkinson IS; Ellis HA; Owen JP; Simpson W; Dewar J
    Kidney Int Suppl; 1986 Feb; 18():S58-64. PubMed ID: 3457998
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminum neurotoxicity and Alzheimer's disease.
    Still CN
    J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of aluminum on bone and cell localization.
    Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S
    Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
    [No Abstract]   [Full Text] [Related]  

  • 14. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
    Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW
    Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006
    [No Abstract]   [Full Text] [Related]  

  • 15. Aluminum and the pathogenesis of dialysis encephalopathy.
    Arieff AI
    Am J Kidney Dis; 1985 Nov; 6(5):317-21. PubMed ID: 3904424
    [No Abstract]   [Full Text] [Related]  

  • 16. [Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
    Espinoza O; Gehrung E; Roessler E; Katz E; Pérez A; Delmastro J
    Rev Med Chil; 1986 Sep; 114(9):867-71. PubMed ID: 3575972
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract]   [Full Text] [Related]  

  • 18. The dialysis dementia syndrome and aluminum intoxication.
    Sideman S; Manor D
    Nephron; 1982; 31(1):1-10. PubMed ID: 7110469
    [No Abstract]   [Full Text] [Related]  

  • 19. Aluminum and phosphate.
    Kaye M; Turner M; Ardila M; Wiegmann T; Hodsman A
    Kidney Int Suppl; 1988 Mar; 24():S172-4. PubMed ID: 3163042
    [No Abstract]   [Full Text] [Related]  

  • 20. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.
    Andress DL; Endres DB; Ott SM; Sherrard DJ
    Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.